Breast Cancer Diagnostics: Start-Ups Look To Fill Gaps In The Patient Care Continuum
This article was originally published in Start Up
Executive Summary
Mammography is a mature and successful breast cancer diagnostic technology, but it has many drawbacks, including high false-negative and false-positive rates, the use of ionizing radiation, and ineffectiveness in dense or scarred breast tissue. Emerging companies aim to improve on this gold standard as well as streamline radiological workflow and predict disease aggressiveness and recurrence. START-UP profiles four such companies in this issue: Delphinus Medical Technologies, Ibris, NovaScan and Real Time Tomography.